Scanning electromicrograph of an HIV-infected T cell. Courtesy of NIAID
The development of a vaccine that protects against HIV infections has proven extraordinarily difficult.
A class of anti-inflammatory drugs already FDA-approved for rheumatoid arthritis could “purge” the reservoir of infected immune cells in people infected by HIV, according to new research.
Researchers at the Duke Human Vaccine Institute have led an effort to develop a more accurate way to gauge the incidence of HIV infections in large populations, which will improve research and prevention strategies worldwide.
A new study suggests that the most beneficial age for a one-time screening HIV test of the general population would be age 25.
While Ottawa researchers are known for their work on cancer-fighting viruses, one team is applying these viruses to a new target: HIV.
If just one-quarter of men who have same-sex intercourse and are at a high risk for HIV used daily preventive medicine, three out of every 10 HIV infections could be averted, according to a new Drexel University study.
A new study has shown that HIV-infected women do not use statins as recommended by the most recent guidelines.